Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Research
[키워드] acute respiratory syndrome
African
antibodies binding
antibody
Antibody neutralization
B.1.1.7 isolate
BNT162b2 mRNA vaccine
caused
chimeric
conserved
convalescent sera
coronavirus
COVID-19 pandemic
E484K
human convalescent sera
human sera
immune
in vitro
in vivo
inhibitory activity
introduced
mAb
mAb cocktail
mAbs
monoclonal
monoclonal antibody
mRNA
N-terminal domain
neutralization
neutralization potency
Neutralizing
polyclonal antibody
Prevent
recipient
reduced
regions
resistance
SARS-CoV-2
SARS-CoV-2 variant
sequence
sera
South
spike gene
spike mutation
spike receptor-binding domain
strain
the receptor-binding domain
Vaccine
variants
Viral variants
virus
[DOI] 10.1038/s41591-021-01294-w [Article Type] Research
[DOI] 10.1038/s41591-021-01294-w [Article Type] Research